These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2350715)

  • 1. Acute leukemia in a patient with ovarian cancer treated with cisplatin-based chemotherapy and alkeran.
    Markman M; Hoskins WB
    Cancer Invest; 1990; 8(1):113-4. PubMed ID: 2350715
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer.
    Reed E; Evans MK
    J Natl Cancer Inst; 1990 Mar; 82(5):431-2. PubMed ID: 2304092
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
    Yokoyama Y; Futagami M; Fukushi Y; Sakamoto T; Higuchi T; Fujii S; Sato S; Takami H; Saito Y
    Arch Gynecol Obstet; 2000 Apr; 263(4):206-7. PubMed ID: 10834334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group.
    Tropé C; Andersson H; Björkholm E; Frankendal B; Himmelman A; Högberg T; Horvath G; Petterson B; Persson H; Ryberg M; Simonsen E; Sorbe B; Stendahl U; Westholm B
    Acta Oncol; 1996; 35 Suppl 8():109-18. PubMed ID: 9073056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary ANLL with t(11;19)(q23;p13) following etoposide and cisplatin for ovarian germ cell tumor.
    Kapoor G; Kadam PR; Chougule A; Gladstone B; Advani SH
    Indian J Cancer; 1997 Jun; 34(2):84-7. PubMed ID: 9491667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute leukemia after chemotherapy (melphalan).
    Einhorn N
    Cancer; 1978 Feb; 41(2):444-7. PubMed ID: 272946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute myeloid leukemia following treatment of IgA-paraproteinemia with alkeran].
    Vögtli W; Nagel GA; Bianchi L; Truog P
    Schweiz Med Wochenschr; 1975 Jan; 105(1):27-8. PubMed ID: 1054885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
    Johansson S; Steineck G; Hursti T; Fredrikson M; Fürst CJ; Peterson C
    Acta Oncol; 1991; 30(5):649-51. PubMed ID: 1832550
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer.
    Cure H; Legros M; Fleury J; Dauplat J; Condat P; Choufi B; Chollet P; Plagne R
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S34-5. PubMed ID: 8899168
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiemetic treatment of chemotherapy-induced nausea in ovarian carcinoma patients.
    Sorbe B; Hallén C
    Gynecol Oncol; 1989 Aug; 34(2):141-4. PubMed ID: 2568970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.
    Gershenson DM; Morris M; Burke TW; Levenback C; Wolf J; Lee JJ; Thall PF; Atkinson EN; Silva EG; Wharton JT
    Cancer; 1999 Dec; 86(11):2291-300. PubMed ID: 10590370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapeutic management of ovarian cancer.
    Dembo AJ
    Semin Oncol; 1984 Sep; 11(3):238-50. PubMed ID: 6435249
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of ovarian cancer.
    Ozols RF; Young RC
    Semin Oncol; 1984 Sep; 11(3):251-63. PubMed ID: 6435250
    [No Abstract]   [Full Text] [Related]  

  • 15. Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery.
    River MS; Fanning J; Sprance HE
    J Surg Oncol; 1991 Sep; 48(1):39-44. PubMed ID: 1890837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabine.
    Markman M
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):33-7. PubMed ID: 4048974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy.
    Gershenson DM; Kavanagh JJ; Copeland LJ; Stringer CA; Morris M; Wharton JT
    Obstet Gynecol; 1989 May; 73(5 Pt 1):798-802. PubMed ID: 2704508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report.
    Brenez D; Devriendt J; Lenclud C; Schmerber J
    Cancer Chemother Pharmacol; 1990; 26(3):235-6. PubMed ID: 2162744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
    Pater JL; Carmichael JA; Krepart GV; Fraser RC; Roy M; Kirk ME; Levitt M; Brown LB; Wilson KS; Shelley WE
    Cancer Treat Rep; 1987 Mar; 71(3):277-81. PubMed ID: 3102056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.